U.S., April 30 -- An application to own the trademark for 'ZOLGENSMA INTHIA' has been filed on Jan. 18, 2024.
Owner(s):
NOVARTIS AG; CH-4002 Basel, , Switzerland
Goods and/or Services:
For: Pharmaceutical preparations and gene therapy products in the nature of injectable biological preparations for the treatment of genetic, neurological, motor neuron, and neuromuscular diseases, disorders, and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials, sold as a unit, for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparations in the nature of biological preparations contain...